Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, placebo controlled, double-blind phase III trial with four
parallel groups studying studying the feasibility of RCT in primary care as well as the
effectiveness of treatment with prednisolone and/or vitamin B1/6/12 for PC19S.
Phase:
Phase 3
Details
Lead Sponsor:
Wuerzburg University Hospital
Collaborators:
University Hospital Schleswig-Holstein University Hospital Tuebingen